Evolent Health (EVH) Depreciation & Amortization (CF) (2015 - 2026)

Evolent Health's Depreciation & Amortization (CF) history runs 12 years deep, the most recent figure standing at $21.6 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 10.4% year-over-year to $21.6 million; the TTM figure through Mar 2026 stood at $113.3 million (changed 0.37% YoY), while the FY2025 annual figure was $115.9 million, down 2.13% from the prior year.
• Depreciation & Amortization (CF) was $21.6 million for Q1 2026 at Evolent Health, down from $45.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $45.0 million in Q4 2025 to a low of $15.1 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $26.3 million across 5 years, with a median of $29.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) soared 112.64% in 2023, then decreased 22.53% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $19.8 million in 2022, then soared by 49.65% to $29.6 million in 2023, then dropped by 1.03% to $29.3 million in 2024, then surged by 53.73% to $45.0 million in 2025, then slumped by 52.14% to $21.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $21.6 million (Q1 2026), $45.0 million (Q4 2025), and $23.6 million (Q3 2025), per Business Quant data.